Influence of membrane ion channel in pituitary somatotrophs by hypothalamic regulators

Cell Calcium

Volumn 51, Issue 3-4, 2012, Pages 231-239

  Yang, Seung Kwon ^a   Steyn, Frederik ^a   Chen, Chen ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Ghrelin; GHRH; Growth hormone; Ion channels; Somatotroph; SRIF

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; CALCIUM ION; CHLORIDE CHANNEL; G PROTEIN COUPLED RECEPTOR; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; ION CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL; SOMATOMEDIN C; SOMATOSTATIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VOLTAGE GATED CALCIUM CHANNEL;

ADENOHYPOPHYSIS; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; EXCITABILITY; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING CELL; HORMONAL REGULATION; HYPOTHALAMUS; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 84862777973     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.12.005     Document Type: Review

References (125)

1. Evans H.M., Long J.A. Characteristic effects upon growth, oestrus and ovulation induced by the intraperitoneal administration of fresh anterior hypophyseal substance. Proc. Natl. Acad. Sci. U.S.A. 1922, 8:38-39.
2. Cuthbertson D.P., Webster T.A., Young F.G. The anterior pituitary gland and protein metabolism. I. Nitrogen-retaining activity of anterior lobe extracts. J. Endocrinol. 1941, 2:459-467.
3. Li C.H., Evans H.M. The isolation of pituitary growth hormone. Science 1944, 99:183-184.
4. Ojeda S.R., Jameson H.E. Development patterns of plasma and pituitary growth hormone (GH) in the female rat. Endocrinology 1977, 100:881-889.
5. Steyn F.J., Huang L., Ngo S.T., Leong J.W., Tan H.Y., Xie T.Y., Parlow A.F., Veldhuis J.D., Waters M.J., Chen C. Development of a method for the determination of pulsatile growth hormone secretion in mice. Endocrinology 2011, 152:3165-3171.
6. Forhman L.A., Jason J.Q. Growth hormone-releasing hormone. Endocr. Rev. 1986, 3:223-253.
7. Giustina A., Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion on experimental animal and the human. Endocr. Rev. 1998, 19:717-797.
8. Mayo K.E. Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol. Endocrinol. 1992, 6:1734-1744.
9. Petersenn S., Schulte H.M. Structure and function of the growth-hormone releasing hormone receptor. Vitam. Horm. 2000, 59:35-69.
10. Root A.W., Root M.J. Clinical pharmacology of human growth hormone and its secretagogues. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2002, 2:27-52.
11. 2+ involvement, cAMP medicated action and additivity of effect with PGE2. Biochem. Biophys. Res. Commun. 1982, 109:588-594.
12. Burton F.H., Hasel K.W., Bloom F.E., Sutcliffe J.G. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 1991, 350:74-77.
13. 2+ concentration and growth hormone (GH) release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin. Endocrinology 1991, 128:592-603.
14. 2+ influx in the ovine somatotroph by growth hormone-releasing factor. Am. J. Physiol. 1995, 268:E204-E212.
15. Roh S.G., He M.L., Matsunaga N., Hidaka S., Hidari H. Mechanisms of action of growth hormone-releasing peptide-2 in bovine pituitary cells. J. Anim. Sci. 1997, 75:2744-2748.
16. Spada A., Vallar L. G-protein oncogenes in acromegaly. Horm. Res. 1992, 38:90-93.
17. Chen C., Vincent J.D., Clarke I.J. Ion channels and signal transduction pathways in the regulation of growth hormone secretion. Trends Endocrinol. Metab. 1994, 5:227-233.
18. Patel P.C., Greenwood M.T., Panetta R., Demchyshy L., Niznik H., Srikant C.B. The somatostatin receptor family. Life Sci. 1995, 57:1249-1265.
19. Parmer R.M., Chan W.W.S., Dashkevicz M., Hayes E.C., Rohrer S.P., Smith R.G., Schaeffer J.M., Blake A.P. Non peptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells. Biochem. Biophys. Res. Commun. 1999, 263:276-280.
20. + currents in GH3 cells through activation of multiple somatostatin receptor. Endocrinology 2005, 146:4965-4984.
21. 2+ currents in GH3 cells through activation of somatostatin receptors 2. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1863-E1870.
22. Chen C., Clarke I.J. Ion channels in the regulation of growth hormone secretion from somatotrophs by somatostatin. Growth Regul. 1992, 2:167-174.
23. Ramirez J.L., Gracia-Navarro F., Garcia-Navarro S., Torronteras R., Malagon M.M., Castano J.P. Somatostatin stimulates GH secretion in two porcine somatotrope subpopulations through cAMP-dependent pathway. Endocrinology 2002, 143:889-897.
24. + channels inhibit the regulatory effects of somatostatin and GH-releasing factor on growth hormone secretion. Biochem. Biophys. Res. Commun. 1992, 187:1007-1014.
25. Le Roith D., Bondy C., Yakar S., Lin J.L., Butler A. The somatomedin hypothesis. Endocr. Rev. 2001, 22:53-74.
26. Berelowitz M., Sazbo M., Frohman L.A., Firoslone S., Cha L., Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1981, 212:1279-1281.
27. Ceda G., Hoffman A.R., Silverberg G.D., Wilson D.M., Rosenfeld R.G. Regulation of growth hormone release from cultures human pituitary adenomas by somatomedin and insulin. J. Clin. Endocrinol. Metab. 1985, 60:1204-1209.
28. Yamashita S., Melmed S. Insulin like growth factor 1 action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acids levels. Endocrinology 1986, 118:176-182.
29. Koerker D.J., Ruch W., Chideckel E., palmer J., Goodner C.J., Ensinck J., Gale C.C. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 1974, 184:482-484.
30. Yamashita S., Weiss M., Melmed S. Insulin-like growth factor 1 regulates growth hormone secretion and messenger ribonucleic acid levels in human pituitary tumor cells. J. Clin. Endocrinol. Metab. 1986, 63:730-735.
31. Dickson S.L., Bailey A.R., Leng G. Growth hormone (GH) secretagogues and neuroendocrine regulation of GH secretion. Growth Horm. IGF Res. 1999, 9(A):89-91.
32. Ghigo E., Arvat E., Broglio F., Giordano R., Gianotti L., Muccioli G., Papotti M., Graziani A., Bisi G., Deghenghi R., Camanni F. Endocrine and non-endocrine activities of growth hormone secretagogues in human. Horm. Res. 1999, 51:9-15.
33. Howard A.D., Feighner S.D., Cully D.F., Arena J., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G., Van der Ploeg L.H. A receptor in pituitary and hypothalamus that in growth hormone release. Science 1996, 273:974-977.
34. Pong S.S., Chaung L.Y., Dean D.C., Nargund R.P., Patchett A.A., Smith R.G. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol. 1996, 10:57-61.
35. Robinson I.C. Hypothalamic targets for growth hormone secretagogues. Acta Paediatr. Suppl. 1997, 423:88-91.
36. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
37. Hosoda K., Kojima M., Matsuo H., Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 2000, 279:909-913.
38. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Marsukura S., Kangawa K., Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rat and humans. Endocrinology 2000, 141:4255-4261.
39. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Kosoda H., Kojima M., Kangawa K., Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 2001, 86:4753-4758.
40. Korbonits M., Bustin S.A., Kojima M., Jordan S., Adams E.F., Lowe D.G., Kangawa K., Grossman A.B. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J. Clin. Endocrinol. Metab. 2001, 86:881-887.
41. Kageyama H., Takenoya F., Shiba K., Shioda S. Neuronal circuits involving ghrelin in the hypothalamic mediated regulation of feeding. Neuropeptides 2010, 44:133-138.
42. Rodriquez-Pacheco F., Luque R.M., Tena-Sempere M., Malaqon M.M., Castano J.P. Ghrelin induces growth hormone secretion via nitric oxide/cGMP signalling pathway. J. Neuroendocrinol. 2008, 20:406-412.
43. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., Papotti M., Muccioli G., Dieguez C., Casanueva F.F., Deghenghi R., Camanni F., Ghigo E. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in human: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 2001, 86:1169-1174.
44. Hataya Y., Akamizu T., Takaya K., Kanamoto N., Ariyasu H., Saijo M., Moriyama K., Shimatsu A., Kojima M., Kangawa K., Nakao K. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing in humans. J. Clin. Endocrinol. Metab. 2001, 86:4552-4555.
45. Seoane L.M., Al-Massadi O., Barreiro F., Diequez C., Casanueva F.F. Growth hormone and somatostatin directly inhibits gastric ghrelin secretion. An in vitro organ culture system. J. Endocrinol. Invest. 2007, 30:RC22-RC25.
46. Bennett P.A., Thomas G.B., Howard A.D., Feighner S.D., Van der Ploeg L.H., Smith R.G., Robinson I.C. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression in regulated by growth hormone in the rat. Endocrinology 1997, 138:4552-4557.
47. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediates through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:47679-54684.
48. Fintini D., Alba M., Schally A.V., Bowers C.T., Parlow A.F., Salvatori R. Effect of combined long-term treatment with a growth hormone-releasing hormone analogue and a growth hormone secretagogues in the growth hormone-releasing hormone knock out mouse. Neuroendocrinology 2005, 82:198-207.
49. Kamegai J., Tamura H., Shimizu T., Ishii S., Tatsuguchi A., Sugihara H., Okikawa S., Kineman R.D. The role of pituitary ghrelin in growth hormone GH secretion. The role of pituitary ghrelin in growth hormone. GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Endocrinology 2004, 145:3731-3738.
50. Wren A.M., Small C.J., Fribbens C.V., Neary N.M., Ward H.L., Seal L.J., Ghatei M.A., Bloom S.R. The hypothalamic mechanism of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002, 76:316-324.
51. Mano-Otagiri A., Nemoto T., Sekino A., Yamauchi N., Shuto Y., Sugihara H., Oikawa S., Shibasaki T. Growth hormone releasing hormone (GHRH) neurons in the arcuate nucleus (Arc) of the hypothalamus are decreased in transgenic rat whose expression of ghrelin receptor is attenuated: evidence that ghrelin receptors are involved in the up-regulation of GHRH expression in the arc. Endocrinology 2006, 147:4093-4103.
52. Sawchenko P.E. Central connections of the sensory and motor nuclei of the vagus nerve. J. Auton. Nerv. Syst. 1983, 9:13-26.
53. van der Kooy D., Koda L.Y., McGinty J.F., Gerfen C.R., Bloom F.E. The organization of projections from the cortex, amygdale, and hypothalamus to the nucleus of the solitary tract in rat. J. Comp. Neurol. 1984, 224:1-24.
54. Schwartz M.W., Woods S.C., Prote D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
55. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Niijima A., Fujino M.A., Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001, 120:337-345.
56. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
57. Al-Massadi O., Trujillo M.L., Senaris R., Pardo M., Castelao C., Casanueva F.F., Seoane L.M. The vagus nerve as a regulator of growth hormone secretion. Regul. Pept. 2011, 166:3-8.
58. + channels in pituitary somatotrophs. Immunol. Cell Biol. 2000, 78:356-368.
59. Catterall W.A., Goldin A.L., Waxman S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 2005, 57:397-409.
60. Reuter H. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 1983, 301:569-574.
61. Tsien R.W Calcium channels in excitable cell membranes. Annu. Rev. Physiol. 1983, 45:341-358.
62. 2+ oscillations by anterior pituitary cells: a comparative overview. Neuroendocrinology 1998, 68:135-151.
63. Kwiecien R., Robert C., Cannon R., Vigues S., Arnoux A., Kordon C., Hammond C. Endogenous pacemaker activity of rat tumour somatotrophs. J. Physiol. 1998, 508:883-905.
64. + channels. J. Gen. Physiol. 1986, 87:817-832.
65. Simasko S.M., Weiland G.A., Oswald R.E. Pharmacological characterization of two calcium currents in GH3 cells. Am. J. Physiol. 1988, 254:328-336.
66. Ritchie A.K. Estrogen increases low voltage-activated calcium current density in GH3 anterior pituitary cells. Endocrinology 1993, 136:3916-3924.
67. Meza U., Avila G., Felix R., Gomora J.C., Cota G. Long-term regulation of calcium channels in clonal pituitary cells by epidermal growth factor, insulin and glucocorticoids. J. Gen. Physiol. 1994, 104:1019-1038.
68. Olivera A., Caramelo C., Arriba G., Lamas S., Rodriguez-Puyol D., Schrier R.W., Rodriguez-Barbero A., Lopez-Novoa J.M. Effect of atrial natriuretic peptide and calcium antagonists on platelet-activating factor-induced contraction and intracellular calcium mobilization in rat megangial cells. J. Cardiovasc. Phamacol. 1994, 24:388-393.
69. Stea A., Soong T.W., Snutch T.P. Determinants of PKC-dependent modulation of a family of neuronal calcium channels. Neuron 1995, 15:929-940.
70. Mori Y., Mikala G., Varadi G., Kobayashi T., Koch S., Wakamori M., Schwartz A. Molecular pharmacology of voltage-dependent calcium channels. J. Pharmacol. 1996, 72:83-109.
71. 2+ channels. Mol. Cell. Neurosci. 1999, 14:255-272.
72. Tsien R.W., Tsien R.Y. Calcium channels, stores, and oscillations. Annu. Rev. Cell Biol. 1990, 6:715-760.
73. 2+ sources. J. Neuroendocrinol. 2004, 16:825-831.
74. 3 cells via cyclic GMP pathways. Endocrine 2011, 10.1007/s12020-011-9520-z.
75. Tsien R.W., Lipscombe D., Madison D.V., Bley K.R., Fox A.P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 1988, 11:431-438.
76. Adams B.A., Beam K.G. A novel calcium current in dysgenic skeletal muscle. J. Gen. Physiol. 1989, 94:429-444.
77. Chen C., Zhang J., Vincent J.D., Israel J.M. Two types of voltage-dependent calcium current in rat somatotrophs are reduced by somatostatin. J. Physiol. 1990, 425:29-42.
78. Martin R.L., Lee J.H., Cribbs L.L., Perez-Reyes E., Hanck D.A. Mibefradil block of cloned T-type calcium channels. J. Pharmacol. Exp. Ther. 2000, 295:302-308.
79. Lee J.H., Gomora J.C., Cribbs L.L., Perez-Reyes E. Nickel block of three cloned T-type calcium channels: low concentrations selectively block α1H. Biophys. J. 1999, 77:3034-3042.
80. Chen C., Zhang J., Vincent J.D., Israel J.M. Somatostatin increases voltage-dependent potassium currents in rat somatotrophs. Am. J. Physiol. 1990, 259:854-861.
81. Plummer M.R., Logothetics D.E., Hess P. Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 1989, 2:1453-1463.
82. Lemos J.R., Nowycky M.C. Two types of calcium channels coexist in peptide-releasing vertebrate nerve terminals. Neuron 1989, 2:1419-1426.
83. Zong S., Yassin M., Tanabe T. G-protein modulation of α1A (P/Q) type calcium channel expressed in GH3 cells. Biochem. Biophys. Res. Commun. 1995, 215:302-308.
84. Mintz I.M., Adams M.E., Bean B.P. P-type calcium channels in rat central and peripheral neurons. Neuron 1992, 9:85-95.
85. 2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 1995, 15:2995-3012.
86. 2+ channels in rat hippocampus. J. Neurosci. 1996, 16:2226-2237.
87. 2+ channels in clonal rat anterior pituitary cells (GH3/B6). Eur. J. Physiol. 2001, 442:577-587.
88. Newcomb R., Szoke B., Palma A., Wang G., Chen X., Hopkins W., Cong R., Miller J., Urge L., Tarczy-hornoch K., Loo J.A., Dooley D.J., Nadasdi L., Tsien R.W., Lemos J., Miljanich G. Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas. Biochemistry 1998, 37:15353-15362.
89. Cuttler L., Glaum S.R., Collins B.A., Miller R.J. Calcium signalling in single growth hormone-releasing factor-responsive pituitary cells. Endocrinology 1992, 130:945-953.
90. Montell C., Rubin G.M. Molecular characterization of the drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 1989, 2(4):1313-1323.
91. Inoue R. TRP channels as a newly emerging non-voltage-gated entry channel superfamily. Curr. Pharm. Des. 2005, 11:1899-1914.
92. Montell C., Birnbaumer L., Flockerzi V. The TRP channels, a remarkably functional family. Cell 2002, 108:595-598.
93. Wimmers S., Karl M.O., Strauss O. Ion channels in the RPE. Prog. Retin. Eye Res. 2007, 26:263-330.
94. Yu F.H., Yarov-Yarovoy V., Gutman G.A., Catterall W.A. Overview of molecular relationships in the voltage-gated ion channel superfamily. Pharmacol. Rev. 2005, 57:387-395.
95. - currents in freshly isolated rat osteoclasts. Pflugers Arch. 1991, 419:3578-4370.
96. Lingle C.J., Sombati S., Freeman M.E. Membrane currents in identified lactotrophs of rat anterior pituitary. J. Neurosci. 1986, 6:2995-3005.
97. Mason W.T., Rawlings S.R. Whole-cell recordings of ionic currents in bovine somatotrophs and their involvement in growth hormone secretion. J. Physiol. 1988, 405:577-593.
98. Ritchie A.K. Two distinct calcium-activated potassium currents in a rat anterior pituitary cell line. J. Physiol. 1987, 385:591-609.
99. + channel in human erythrocytes. Int. J. Biochem. Cell Biol. 2003, 35:1182-1197.
100. Galvex A., Gimenez-Gallego G., Reuben J.P., Roy-Contancin L., Feigenbaum P., Kaczorowski G.J., Garcia M.L. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tumulus. J. Biol. Chem. 1990, 265:11083-11090.
101. + transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins. J. Biol. Chem. 1993, 268:8760-9768.
102. Van Goor F., Zivadinovic D., Martinez-Fuentes A.J., Stojilkovic S.S. Dependence of pituitary hormone secretion on the pattern of spontaneous voltage-gates calcium influx. Cell type-specific action potential secretion coupling. J. Biol. Chem. 2001, 276:33840-33846.
103. Castle N.A., Haylett D.G., Jenkinson D.H. Toxin in the characterization of potassium channels. Trends Neurosci. 1989, 12:59-65.
104. Faber E.S., Sah P. Physiological role of calcium-activated potassium currents in the rat lateral amygdale. J. Neurosci. 2002, 22:1618-1628.
105. + channel of intermediate conductance: a molecular target for novel treatments?. Curr. Drug Target 2001, 2:401-422.
106. Coleman H.A., Tare M., Parkington H.C. Endothelial potassium channels, endothelium-dependent hyperpolarization, and the regulation of vascular tone in health and in disease. Clin. Exp. Pharmacol. Physiol. 2004, 31:641-649.
107. 2+ channels in rat brain. J. Biol. Chem. 2004, 279:36445-36453.
108. Loussouarn G., Rose T., Nichols C.G. Structural basis of inward rectifying potassium channel gating. Trends Cardiovasc. Med. 2002, 12:253-258.
109. Bauer C.K., Engeland B., Wulfsen I., Ludwig J., Pongs O., Schwarz J.R. RERG is a molecule correlate of the inward-rectifying K current in clonal rat pituitary cells. Receptors Channels 1998, 6:19-29.
110. Piros E.T., Charles R.C., Song L., Evans C.J., Hales T.G. Cloned delta-opioid receptors in GH(3) cells inhibit spontaneous Ca(2+) oscillations and prolactin release through K(IR) channel activation. J. Neurophysiol. 2000, 83:2691-2698.
111. Goldstein S.A., Bayliss D.A., Kim D., Lesage F., Plant L.D., Rajan S. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol. Rev. 2005, 57:527-540.
112. Plant L.D., Rajan S., Goldstein S.A. K2P channels and their protein partners. Curr. Opin. Neurobiol. 2005, 15:326-333.
113. 2+ channels in gonadotropin-releasing hormone-induced membrane potential changes in identified rat gonadotropes. Endocrinology 1993, 132:1475-1481.
114. Goldin A.L. Resurgence of sodium channel research. Annu. Rev. Physiol. 2001, 63:871-894.
115. Nau C. Voltage-gate ion channels. Handb. Exp. Pharmacol. 2008, 182:85-92.
116. Hille B. The superfamily of voltage-gated channels. Ion Channels of Excitable Membranes 2001, Sinauer Associates, Sunderland, MA, pp. 62-94.
117. Cummins T.R., Dib-Hajj S.D., Black A., Akopian A.N., Wood J.N., Waxman S.G. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J. Neurosci. 1999, 19:RC43.
118. + current and protein kinase C in the action of growth hormone (GH)-releasing hormone on primary cultured somatotropes from GH-green fluorescent protein transgenic mice. Endocrinology 2008, 149:4726-4735.
119. + current in the primary cultured rat somatotrophs. Endocrinology 1997, 138:5096-5100.
120. + current in cultured rat pituitary cells. Am. J. Physiol. 1996, 270:125-130.
121. + on GRF-induced GH secretion from rat pituitary cells. Am. J. Physiol. 1989, 256:C712-C718.
122. Nilius B., Droogmans G. Amazing chloride channels. Acta Physiol. Scand. 2003, 177:119-147.
123. - channels gleaned from human genetic disease and mouse models. Annu. Rev. Physiol. 2005, 67:779-807.
124. Zhang S.J., Jackson M.B. GABA-activated chloride channels in secretory nerve endings. Science 1993, 259:531-534.
125. Zhang S.J., Jackson M.B. Properties of rat posterior pituitary nerve terminals. J. Neurophysiol. 1995, 73:1135-1144.